Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Fluconazole Monotherapy Is a Suboptimal Option for Initial Treatment of Cryptococcal Meningitis Because of Emergence of Resistance.

Hope W, Stone NRH, Johnson A, McEntee L, Farrington N, Santoro-Castelazo A, Liu X, Lucaci A, Hughes M, Oliver JD, Giamberardino C, Mfinanga S, Harrison TS, Perfect JR, Bicanic T.

mBio. 2019 Dec 3;10(6). pii: e02575-19. doi: 10.1128/mBio.02575-19.

2.

Clinical outcomes of new algorithm for diagnosis and treatment of Tuberculosis sepsis in HIV patients.

Byashalira K, Mbelele P, Semvua H, Chilongola J, Semvua S, Liyoyo A, Mmbaga B, Mfinanga S, Moore C, Heysell S, Mpagama S.

Int J Mycobacteriol. 2019 Oct-Dec;8(4):313-319. doi: 10.4103/ijmy.ijmy_135_19.

3.
4.

Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: a cost-effectiveness analysis.

Kimaro GD, Guinness L, Shiri T, Kivuyo S, Chanda D, Bottomley C, Chen T, Kahwa A, Hawkins N, Mwaba P, Mfinanga SG, Harrison TS, Jaffar S, Niessen LW.

Clin Infect Dis. 2019 May 31. pii: ciz453. doi: 10.1093/cid/ciz453. [Epub ahead of print]

5.

Health Beliefs and Patient Perspectives of Febrile Illness in Kilombero, Tanzania.

Hercik C, Cosmas L, Mogeni OD, Kohi W, Mfinanga S, Loffredo C, Montgomery JM.

Am J Trop Med Hyg. 2019 Jul;101(1):263-270. doi: 10.4269/ajtmh.17-0862.

PMID:
31115309
6.

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa.

Chen T, Mwenge L, Lakhi S, Chanda D, Mwaba P, Molloy SF, Gheorghe A, Griffiths UK, Heyderman RS, Kanyama C, Kouanfack C, Mfinanga S, Chan AK, Temfack E, Kivuyo S, Hosseinipour MC, Lortholary O, Loyse A, Jaffar S, Harrison TS, Niessen LW; ACTA Trial Team.

Clin Infect Dis. 2019 Aug 1;69(4):588-595. doi: 10.1093/cid/ciy971.

7.

Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S58-S61. doi: 10.1016/j.ijid.2019.02.035. Epub 2019 Feb 26.

8.

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.

Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman RS, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS.

Clin Infect Dis. 2020 Jan 1;70(1):26-29. doi: 10.1093/cid/ciz163.

9.

Tuberculin skin test - Outdated or still useful for Latent TB infection screening?

Gualano G, Mencarini P, Lauria FN, Palmieri F, Mfinanga S, Mwaba P, Chakaya J, Zumla A, Ippolito G.

Int J Infect Dis. 2019 Mar;80S:S20-S22. doi: 10.1016/j.ijid.2019.01.048. Epub 2019 Feb 6. Review.

10.

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis.

Stone NR, Rhodes J, Fisher MC, Mfinanga S, Kivuyo S, Rugemalila J, Segal ES, Needleman L, Molloy SF, Kwon-Chung J, Harrison TS, Hope W, Berman J, Bicanic T.

J Clin Invest. 2019 Mar 1;129(3):999-1014. doi: 10.1172/JCI124516. Epub 2019 Jan 28.

11.

Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future.

Rao M, Ippolito G, Mfinanga S, Ntoumi F, Yeboah-Manu D, Vilaplana C, Zumla A, Maeurer M.

Int J Infect Dis. 2019 Mar;80S:S62-S67. doi: 10.1016/j.ijid.2019.01.039. Epub 2019 Jan 24.

12.

Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults.

Mbelele PM, Mohamed SY, Sauli E, Mpolya EA, Mfinanga SG, Addo KK, Heysell SK, Mpagama SG.

Int J Mycobacteriol. 2018 Oct-Dec;7(4):299-309. doi: 10.4103/ijmy.ijmy_135_18.

13.

Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era.

Petersen E, Abubakar I, Ihekweazu C, Heymann D, Ntoumi F, Blumberg L, Asogun D, Mukonka V, Lule SA, Bates M, Honeyborne I, Mfinanga S, Mwaba P, Dar O, Vairo F, Mukhtar M, Kock R, McHugh TD, Ippolito G, Zumla A.

Int J Infect Dis. 2019 Jan;78:78-84. doi: 10.1016/j.ijid.2018.11.008. Epub 2018 Nov 16. Review.

14.

Household Air Pollution Is Associated with Chronic Cough but Not Hemoptysis after Completion of Pulmonary Tuberculosis Treatment in Adults, Rural Eastern Democratic Republic of Congo.

Katoto PDMC, Murhula A, Kayembe-Kitenge T, Lawin H, Bisimwa BC, Cirhambiza JP, Musafiri E, Birembano F, Kashongwe Z, Kirenga B, Mfinanga S, Mortimer K, De Boever P, Nawrot TS, Nachega JB, Nemery B.

Int J Environ Res Public Health. 2018 Nov 15;15(11). pii: E2563. doi: 10.3390/ijerph15112563.

15.

Pharmacokinetics of First-Line Drugs Among Children With Tuberculosis in Rural Tanzania.

Justine M, Yeconia A, Nicodemu I, Augustino D, Gratz J, Mduma E, Heysell SK, Kivuyo S, Mfinanga S, Peloquin CA, Zagurski T, Kibiki GS, Mmbaga B, Houpt ER, Thomas TA.

J Pediatric Infect Dis Soc. 2018 Nov 5. doi: 10.1093/jpids/piy106. [Epub ahead of print]

PMID:
30395239
16.

Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.

Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS.

Lancet Infect Dis. 2019 Apr;19(4):e143-e147. doi: 10.1016/S1473-3099(18)30493-6. Epub 2018 Oct 18. Review.

PMID:
30344084
17.

Integrated care for human immunodeficiency virus, diabetes and hypertension in Africa.

Garrib A, Birungi J, Lesikari S, Namakoola I, Njim T, Cuevas L, Niessen L, Mugisha K, Mutungi G, Mghamba J, Ramaiya K, Jaffar S, Mfinanga S, Nyirenda M.

Trans R Soc Trop Med Hyg. 2019 Dec 1;113(12):809-812. doi: 10.1093/trstmh/try098.

PMID:
30265362
18.

Geospatial distribution of Mycobacterium tuberculosis genotypes in Africa.

Chihota VN, Niehaus A, Streicher EM, Wang X, Sampson SL, Mason P, Källenius G, Mfinanga SG, Pillay M, Klopper M, Kasongo W, Behr MA, Gey van Pittius NC, van Helden PD, Couvin D, Rastogi N, Warren RM.

PLoS One. 2018 Aug 1;13(8):e0200632. doi: 10.1371/journal.pone.0200632. eCollection 2018.

19.

Knowledge and perception on type2 diabetes and hypertension among HIV clients utilizing care and treatment services: a cross sectional study from Mbeya and Dar es Salaam regions in Tanzania.

Kagaruki GB, Mayige MT, Ngadaya ES, Kilale AM, Kahwa A, Shao AF, Kimaro GD, Manga CM, Mbata D, Materu GS, Masumo RM, Mfinanga SG.

BMC Public Health. 2018 Jul 28;18(1):928. doi: 10.1186/s12889-018-5639-7.

20.

Accessibility of Early Infant Diagnostic Services by Under-5 Years and HIV Exposed Children in Muheza District, North-East Tanzania.

Bwana VM, Mfinanga SG, Simulundu E, Mboera LEG, Michelo C.

Front Public Health. 2018 May 15;6:139. doi: 10.3389/fpubh.2018.00139. eCollection 2018.

21.

Genome sequence of Mycobacterium yongonense RT 955-2015 isolate from a patient misdiagnosed with multidrug-resistant tuberculosis: First clinical detection in Tanzania.

Mnyambwa NP, Kim DJ, Ngadaya E, Chun J, Ha SM, Petrucka P, Addo KK, Kazwala RR, Mfinanga SG.

Int J Infect Dis. 2018 Jun;71:82-88. doi: 10.1016/j.ijid.2018.04.796. Epub 2018 Apr 24.

22.

Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies.

Tiberi S, du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A.

Lancet Infect Dis. 2018 Jul;18(7):e183-e198. doi: 10.1016/S1473-3099(18)30110-5. Epub 2018 Mar 23. Review. Erratum in: Lancet Infect Dis. 2018 Apr 27;:.

PMID:
29580819
23.

Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB".

Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, Vilaplana C, Dar O, Bates M, Corrah T, Rao M, Kapata N, Azhar EI, Memish ZA, Mfinanga S, Aseffa A, Ippolito G, Migliori GB, Zumla A.

Int J Infect Dis. 2018 Mar;68:122-124. doi: 10.1016/j.ijid.2018.03.002. Epub 2018 Mar 22. No abstract available.

24.

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team.

N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.

25.

Assessment of GeneXpert GxAlert platform for multi-drug resistant tuberculosis diagnosis and patients' linkage to care in Tanzania.

Mnyambwa NP, Lekule I, Ngadaya ES, Kimaro G, Petrucka P, Kim DJ, Lymo J, Kazwala R, Mosha F, Mfinanga SG.

BMC Res Notes. 2018 Feb 9;11(1):121. doi: 10.1186/s13104-018-3235-7.

26.

A diagnostic and epidemiologic investigation of acute febrile illness (AFI) in Kilombero, Tanzania.

Hercik C, Cosmas L, Mogeni OD, Wamola N, Kohi W, Omballa V, Ochieng M, Lidechi S, Bonventure J, Ochieng C, Onyango C, Fields BS, Mfinanga S, Montgomery JM.

PLoS One. 2017 Dec 29;12(12):e0189712. doi: 10.1371/journal.pone.0189712. eCollection 2017.

27.

A Combined Syndromic Approach to Examine Viral, Bacterial, and Parasitic Agents among Febrile Patients: A Pilot Study in Kilombero, Tanzania.

Hercik C, Cosmas L, Mogeni OD, Wamola N, Kohi W, Houpt E, Liu J, Ochieng C, Onyango C, Fields B, Mfinanga S, Montgomery JM.

Am J Trop Med Hyg. 2018 Feb;98(2):625-632. doi: 10.4269/ajtmh.17-0421. Epub 2017 Dec 21.

28.

'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania.

Miller C, Huston J, Samu L, Mfinanga S, Hopewell P, Fair E.

Int J Tuberc Lung Dis. 2017 Nov 1;21(11):42-48. doi: 10.5588/ijtld.16.0914.

PMID:
29025484
29.

Efficacy of standardized extract of Hibiscus sabdariffa L. (Malvaceae) in improving iron status of adults in malaria endemic area: A randomized controlled trial.

Peter EL, Rumisha SF, Mashoto KO, Minzi OM, Mfinanga S.

J Ethnopharmacol. 2017 Sep 14;209:288-293. doi: 10.1016/j.jep.2017.07.037. Epub 2017 Jul 26.

PMID:
28755971
30.

Assessment of sputum smear-positive but culture-negative results among newly diagnosed pulmonary tuberculosis patients in Tanzania.

Mnyambwa NP, Ngadaya ES, Kimaro G, Kim DJ, Kazwala R, Petrucka P, Mfinanga SG.

Int J Gen Med. 2017 Jul 12;10:199-205. doi: 10.2147/IJGM.S137469. eCollection 2017.

31.

Cryptococcal meningitis: A neglected NTD?

Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A.

PLoS Negl Trop Dis. 2017 Jun 29;11(6):e0005575. doi: 10.1371/journal.pntd.0005575. eCollection 2017 Jun. No abstract available.

32.

Isolation, biochemical and molecular identification of Nocardia species among TB suspects in northeastern, Tanzania; a forgotten or neglected threat?

Hoza AS, Mfinanga SGS, Moser I, König B.

BMC Infect Dis. 2017 Jun 8;17(1):407. doi: 10.1186/s12879-017-2520-8.

33.

Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.

Mnyambwa NP, Kim DJ, Ngadaya ES, Kazwala R, Petrucka P, Mfinanga SG.

Eur J Clin Microbiol Infect Dis. 2017 Nov;36(11):2021-2028. doi: 10.1007/s10096-017-3027-3. Epub 2017 Jun 7. Review.

PMID:
28593375
34.

The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.

Kimaro GD, Mfinanga S, Simms V, Kivuyo S, Bottomley C, Hawkins N, Harrison TS, Jaffar S, Guinness L; REMSTART trial team.

PLoS One. 2017 Feb 24;12(2):e0171917. doi: 10.1371/journal.pone.0171917. eCollection 2017.

35.

Father absence but not fosterage predicts food insecurity, relative poverty, and poor child health in northern Tanzania.

Lawson DW, Schaffnit SB, Hassan A, Ngadaya E, Ngowi B, Mfinanga SGM, James S, Borgerhoff Mulder M.

Am J Hum Biol. 2017 May 6;29(3). doi: 10.1002/ajhb.22938. Epub 2016 Nov 16.

PMID:
27862534
36.

Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.

Senkoro M, Kumar AM, Chinnakali P, Mfinanga SG, Egwaga S, Kamara V, van Leth F, Hinderaker SG.

Int J Tuberc Lung Dis. 2016 Oct;20(10):1326-1333. Erratum in: Int J Tuberc Lung Dis. 2017 Sep 1;21(9):1070.

PMID:
27725043
37.

Prevalence of pulmonary tuberculosis in adult population of Tanzania: a national survey, 2012.

Senkoro M, Mfinanga S, Egwaga S, Mtandu R, Kamara DV, Basra D, Fundikira L, Kahwa A, Shirima R, Range N, Hinderaker SG, van Leth F.

Int J Tuberc Lung Dis. 2016 Aug;20(8):1014-21. doi: 10.5588/ijtld.15.0340.

PMID:
27393533
38.

Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential.

Zumla A, Dar O, Kock R, Muturi M, Ntoumi F, Kaleebu P, Eusebio M, Mfinanga S, Bates M, Mwaba P, Ansumana R, Khan M, Alagaili AN, Cotten M, Azhar EI, Maeurer M, Ippolito G, Petersen E.

Int J Infect Dis. 2016 Jun;47:5-9. doi: 10.1016/j.ijid.2016.06.012. Epub 2016 Jun 15.

39.

Who Has Mycobacterial Disease? A Cross Sectional Study in Agropastoral Communities in Tanzania.

Kilale AM, Ngadaya E, Muhumuza J, Kagaruki GB, Lema YL, Ngowi BJ, Mfinanga SG, Hinderaker SG.

PLoS One. 2016 May 23;11(5):e0153711. doi: 10.1371/journal.pone.0153711. eCollection 2016.

40.

Molecular characterization of Mycobacterium tuberculosis isolates from Tanga, Tanzania: First insight of MIRU-VNTR and microarray-based spoligotyping in a high burden country.

Hoza AS, Mfinanga SG, Moser I, König B.

Tuberculosis (Edinb). 2016 May;98:116-24. doi: 10.1016/j.tube.2016.02.002. Epub 2016 Mar 29.

PMID:
27156627
41.

Taking forward the World TB Day 2016 theme 'Unite to End Tuberculosis' for the WHO Africa Region.

Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-Manu D, Bates M, Mwaba P, Maeurer M, Petersen E, Zumla A.

Int J Infect Dis. 2016 May;46:34-7. doi: 10.1016/j.ijid.2016.03.003. Epub 2016 Mar 8.

42.

Reply to Rieger and Wagner: Context matters when studying purportedly harmful cultural practices.

Lawson DW, James S, Ngadaya E, Ngowi B, Mfinanga SG, Borgerhoff Mulder M.

Proc Natl Acad Sci U S A. 2016 Mar 29;113(13):E1771-2. doi: 10.1073/pnas.1601420113. Epub 2016 Mar 2. No abstract available.

43.

Increased isolation of nontuberculous mycobacteria among TB suspects in Northeastern, Tanzania: public health and diagnostic implications for control programmes.

Hoza AS, Mfinanga SG, Rodloff AC, Moser I, König B.

BMC Res Notes. 2016 Feb 17;9:109. doi: 10.1186/s13104-016-1928-3.

44.

Screening for pulmonary tuberculosis in a Tanzanian prison and computer-aided interpretation of chest X-rays.

Steiner A, Mangu C, van den Hombergh J, van Deutekom H, van Ginneken B, Clowes P, Mhimbira F, Mfinanga S, Rachow A, Reither K, Hoelscher M.

Public Health Action. 2015 Dec 21;5(4):249-54. doi: 10.5588/pha.15.0037.

45.

Anti-TB drug resistance in Tanga, Tanzania: A cross sectional facility-base prevalence among pulmonary TB patients.

Hoza AS, Mfinanga SGM, König B.

Asian Pac J Trop Med. 2015 Nov;8(11):907-913. doi: 10.1016/j.apjtm.2015.10.014. Epub 2015 Oct 9.

46.

No evidence that polygynous marriage is a harmful cultural practice in northern Tanzania.

Lawson DW, James S, Ngadaya E, Ngowi B, Mfinanga SG, Borgerhoff Mulder M.

Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):13827-32. doi: 10.1073/pnas.1507151112. Epub 2015 Oct 26.

47.

Towards host-directed therapies for tuberculosis.

Zumla A, Maeurer M; Host-Directed Therapies Network, Chakaya J, Hoelscher M, Ntoumi F, Rustomjee R, Vilaplana C, Yeboah-Manu D, Rasolof V, Munderi P, Singh N, Aklillu E, Padayatchi N, Macete E, Kapata N, Mulenga M, Kibiki G, Mfinanga S, Nyirenda T, Maboko L, Garcia-Basteiro A, Rakotosamimanana N, Bates M, Mwaba P, Reither K, Gagneux S, Edwards S, Mfinanga E, Abdulla S, Cardona PJ, Russell JB, Gant V, Noursadeghi M, Elkington P, Bonnet M, Menendez C, Dieye TN, Diarra B, Maiga A, Aseffa A, Parida S, Wejse C, Petersen E, Kaleebu P, Oliver M, Craig G, Corrah T, Tientcheu L, Antonio M, Rao M, McHugh TD, Sheikh A, Ippolito G, Ramjee G, Kaufmann SH, Churchyard G, Steyn A, Grobusch M, Sanne I, Martinson N, Madansein R, Wilkinson RJ, Mayosi B, Schito M, Wallis RS.

Nat Rev Drug Discov. 2015 Aug;14(8):511-2. doi: 10.1038/nrd4696. Epub 2015 Jul 17.

PMID:
26184493
48.

Experienced and Perceived Risks of Mycobacterial Diseases: A Cross Sectional Study among Agropastoral Communities in Northern Tanzania.

Kilale AM, Ngadaya E, Kagaruki GB, Lema YL, Muhumuza J, Ngowi BJ, Mfinanga SG, Hinderaker SG.

PLoS One. 2015 Jun 24;10(6):e0130180. doi: 10.1371/journal.pone.0130180. eCollection 2015.

49.

Multiplex Analysis of Pro- or Anti-Inflammatory Serum Cytokines and Chemokines in relation to Gender and Age among Tanzanian Tuberculous Lymphadenitis Patients.

Mustafa T, Brokstad KA, Mfinanga SG, Wiker HG.

Tuberc Res Treat. 2015;2015:561490. doi: 10.1155/2015/561490. Epub 2015 Apr 28.

50.

One Health: a concept led by Africa, with global benefits.

Kamani TM, Kazwala R, Mfinanga S, Haydon D, Keyyu J, Lankester F, Buza J.

Vet Rec. 2015 May 9;176(19):496-7. doi: 10.1136/vr.h2461. No abstract available.

Supplemental Content

Loading ...
Support Center